Maymon Ron, Sharony Reuven, Grinshpun-Cohen Julia, Itzhaky Deganit, Herman Arie, Reish Orit
Department of Obstetrics and Gynecology, Assaf Harofe Medical Center, Israel.
J Perinat Med. 2005;33(5):392-8. doi: 10.1515/JPM.2005.071.
To evaluate the cross-trimester multiple marker correlation and the minimum marker combination needed for detecting various chromosomal aneuploidies.
Parturient women with singleton pregnancies who underwent non-interventional sequential screening test and followed prospectively were recruited. They all underwent first trimester combined nuchal translucency (NT), pregnancy-associated plasma protein-A (PAPP-A), and free beta-human chorionic gonadotrophin (f-betahCG), followed by second trimester measurement of unconjugated estriol (uE3), human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP). Pearson correlation was applied to compute any cross-trimester marker correlation and logistic regression analysis was used to determine the minimum marker combination for detecting various categories of chromosomal aneuploidies.
The current study included 552 normal and 43 chromosomal-affected pregnancies (24 Down's syndrome [DS], 7 Turner's syndrome, 8 Edward's syndrome, 4 Klinefelter syndrome and 5 triploidy) for which the results of both the screening tests and the pregnancy outcome were available. In the normal cases, a significant correlation was found between f-betahCG and hCG (r=0.52), as well as between PAPP-A and uE3 (r=0.174). In DS pregnancies, the NT correlated with both hCG (r=0.45) and uE3 (r=-0.39). In Turner's syndrome, uE3 correlated both with PAPP-A (r=0.97) and f-betahCG (r=0.97). No other significant correlations were found. Furthermore, with the exception of f-betahCG and hCG in the unaffected cases, all other markers correlation appeared very weak. For detecting all the above categories of aneuploidies, the combination of NT, PAPP-A and uE3 and the maternal age background risk were found adequate, with a 74% detection rate (DR) for a 5% false positive rate (FPR). For DS only, the combination of maternal age-related background risk and the combination of NT, PAPP-A, hCG and AFP yielded a 79% DR for a 5% FPR.
The current study agrees with a previous report that, overall, there is no strong correlation between first and second trimester markers. The extension of the integrated test for detecting various categories of common chromosomal aneuploidies using NT, PAPP-A and uE3 deserves further evaluation.
评估跨孕期多种标志物的相关性以及检测各种染色体非整倍体所需的最小标志物组合。
招募接受非介入性序贯筛查试验并进行前瞻性随访的单胎妊娠产妇。她们均在孕早期接受了联合颈部透明带(NT)、妊娠相关血浆蛋白A(PAPP-A)和游离β-人绒毛膜促性腺激素(f-βhCG)检测,随后在孕中期测量了非结合雌三醇(uE3)、人绒毛膜促性腺激素(hCG)和甲胎蛋白(AFP)。应用Pearson相关性分析计算任何跨孕期标志物的相关性,并使用逻辑回归分析确定检测各种染色体非整倍体类别的最小标志物组合。
本研究纳入了552例正常妊娠和43例染色体异常妊娠(24例唐氏综合征[DS]、7例特纳综合征、8例爱德华兹综合征、4例克兰费尔特综合征和5例三倍体),这些妊娠均有筛查试验结果和妊娠结局。在正常病例中,发现f-βhCG与hCG之间存在显著相关性(r = 0.52),以及PAPP-A与uE3之间存在显著相关性(r = 0.174)。在DS妊娠中,NT与hCG(r = 0.45)和uE3(r = -0.39)均相关。在特纳综合征中,uE3与PAPP-A(r = 0.97)和f-βhCG(r = 0.97)均相关。未发现其他显著相关性。此外,除了未受影响病例中的f-βhCG和hCG外,所有其他标志物的相关性都非常弱。为了检测上述所有类别的非整倍体,发现NT、PAPP-A和uE3与母亲年龄背景风险的组合足够,在5%假阳性率(FPR)下检测率(DR)为74%。仅对于DS,母亲年龄相关背景风险与NT、PAPP-A、hCG和AFP的组合在5% FPR下产生了79%的DR。
本研究与先前的报告一致,总体而言,孕早期和孕中期标志物之间没有强相关性。使用NT、PAPP-A和uE3扩展综合检测以检测各种常见染色体非整倍体类别值得进一步评估。